Anna Capasso, MD

Assistant Professor

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Colorectal Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Aurora Kinases Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2018

Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer

Klauck, P. J., Bagby, S. M., Capasso, A., Bradshaw-Pierce, E. L., Selby, H. M., Spreafico, A., Tentler, J. J., Tan, A. C., Kim, J., Arcaroli, J. J., Purkey, A., Messersmith, W. A., Kuida, K., Eckhardt, S. G. & Pitts, T. M., Feb 5 2018, In : BMC Cancer. 18, 1, 136.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Cell Line
Inhibitory Concentration 50

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Diamond, J. R., Eckhardt, S. G., Pitts, T. M., van Bokhoven, A., Aisner, D., Gustafson, D. L., Capasso, A., Sams, S., Kabos, P., Zolman, K., Colvin, T., Elias, A. D., Storniolo, A. M., Schneider, B. P., Gao, D., Tentler, J. J., Borges, V. F. & Miller, K. D., Aug 2 2018, In : Breast Cancer Research. 20, 1, 82.

Research output: Contribution to journalArticle

Aurora Kinases
Triple Negative Breast Neoplasms
Phase II Clinical Trials
Angiogenesis Inhibitors

BRAF fusions identified in melanomas have variable treatment responses and phenotypes

Turner, J. A., Bemis, J. G. T., Bagby, S. M., Capasso, A., Yacob, B. W., Chimed, T. S., Van Gulick, R., Lee, H., Tobin, R., Tentler, J. J., Pitts, T., McCarter, M., Robinson, W. A. & Couts, K. L., Jan 1 2018, (Accepted/In press) In : Oncogene.

Research output: Contribution to journalArticle

RNA Sequence Analysis
1 Citations

Cabozantinib exhibits potent antitumor activity in colorectal cancer patient-derived tumor xenograft models via autophagy and signaling mechanisms

Scott, A. J., Arcaroli, J. J., Bagby, S. M., Yahn, R., Huber, K. M., Serkova, N. J., Nguyen, A., Kim, J., Thorburn, A., Vogel, J., Quackenbush, K. S., Capasso, A., Schreiber, A., Blatchford, P., Klauck, P. J., Pitts, T. M., Eckhardt, S. G. & Messersmith, W. A., Oct 1 2018, In : Molecular Cancer Therapeutics. 17, 10, p. 2112-2122 11 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms

Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models

Capasso, A., Pitts, T. M., Klauck, P. J., Bagby, S. M., Westbrook, L., Kaplan, J., Soleimani, M., Spreafico, A., Tentler, J. J., Diamond, J. R., Arcaroli, J. J., Messersmith, W. A., Eckhardt, S. G. & Leong, S., Oct 1 2018, In : Anti-Cancer Drugs. 29, 9, p. 827-838 12 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Cell Cycle
Cell Line